Profile: Landauer, Inc. deals with personnel radiation monitoring with a third generation proprietary technology known as optically stimulated luminescence(OSL).We monitor personnel exposure to ionizing radiation used in diagnostic X-ray, radiation therapy, nuclear medicine, radio-pharmaceuticals, research manufacturing, research, and nuclear power. We ensure accurate and reliable radiation monitoring & precise dose measurements in any environment with potential exposure to low & high-energy photons, beta particles, electrons & neutrons, as well as radon gas. Our InLight® on-site solutions are scalable, from manual single dose measurement to automatic multi-dosimeter analysis options. They are ideal for small laboratories processing dosimeters in-house to full service laboratories providing personnel services. This system can quickly determine the severity of an exposure or precisely track dose over time.

The company was founded in 1954, has revenues of USD 50-100 Million, has ~300 employees and is ISO certified. NYSE:LDR (SEC Filings)

FDA Registration Number: 3008426232